Elite Pharmaceuticals, Inc. Announces First Shipment of Generic Hydromorphone Product
Published: Mar 13, 2012
NORTHVALE, N.J., March 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today the initial shipment of hydromorphone hydrochloride 8 mg tablets, the generic equivalent of Dilaudid® 8 mg tablets under the License, Manufacturing and Supply Agreement with its sales and marketing partner, triggering a milestone payment. Elite's sales and marketing partner will distribute the product as part of a multi-product distribution agreement.